Jian-Chuan Xia (Jianchuan Xia, Jian Chuan Xia)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Clinical and translational medicine

Journal for immunotherapy of cancer

Oncogene

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics 23 (8) (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene 43 (28) (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Yuanyuan Chen, Dijun Ouyang, Yan Wang, Qiuzhong Pan, Jingjing Zhao, Hao Chen, Xinyi Yang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Jin-Qi You, Yingzi Li, Chi Xu, Yan Ren, Sisi Xie, Song Li, Jiamin Lian, Desheng Weng, Tong Xiang, Jian-Chuan Xia
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion. Journal for immunotherapy of cancer 12 (6) (2024)
Meng-Jia Song, Chaoqi Zhang, Shaoyan Cheng, Dijun Ouyang, Yu Ping, Jieying Yang, Yao-Jun Zhang, Yan Tang, Hao Chen, Qi-Jing Wang, Yong-Qiang Li, Jia He, Tong Xiang, Yi-Zhuo Zhang, Jian-Chuan Xia
DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma. Cancer research 84 (10) (2024)
Meng-Jia Song, Chaoqi Zhang, Shaoyan Cheng, Dijun Ouyang, Yu Ping, Jieying Yang, Yao-Jun Zhang, Yan Tang, Hao Chen, Qi-Jing Wang, Yong-Qiang Li, Jia He, Tong Xiang, Yi-Zhuo Zhang, Jian-Chuan Xia
DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma. Cancer research 84 (10) (2024)
Yuanyuan Chen, Dijun Ouyang, Yan Wang, Qiuzhong Pan, Jingjing Zhao, Hao Chen, Xinyi Yang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Jin-Qi You, Yingzi Li, Chi Xu, Yan Ren, Sisi Xie, Song Li, Jiamin Lian, Desheng Weng, Tong Xiang, Jian-Chuan Xia
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion. Journal for immunotherapy of cancer 12 (6) (2024)
Meng-Jia Song, Chaoqi Zhang, Shaoyan Cheng, Dijun Ouyang, Yu Ping, Jieying Yang, Yao-Jun Zhang, Yan Tang, Hao Chen, Qi-Jing Wang, Yong-Qiang Li, Jia He, Tong Xiang, Yi-Zhuo Zhang, Jian-Chuan Xia
DNA of neutrophil extracellular traps binds TMCO6 to impair CD8+ T-cell immunity in hepatocellular carcinoma. Cancer research (2024)
Yuanyuan Chen, Dijun Ouyang, Yan Wang, Qiuzhong Pan, Jingjing Zhao, Hao Chen, Xinyi Yang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Jin-Qi You, Yingzi Li, Chi Xu, Yan Ren, Sisi Xie, Song Li, Jiamin Lian, Desheng Weng, Tong Xiang, Jian-Chuan Xia
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion. Journal for immunotherapy of cancer 12 (6) (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene 43 (28) (2024)
Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics (2024)
Meng-Jia Song, Yue Huang, Ye Hong, Juan Liu, Jia Zhu, Suying Lu, Juan Wang, Feifei Sun, Junting Huang, Jiaqian Xu, Yan Tang, Jian-Chuan Xia, Yizhuo Zhang
PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma. Oncoimmunology 13 (1) (2023)
Yulong Han, Qiuzhong Pan, Zhixing Guo, Yufei Du, Yaojun Zhang, Yingying Liu, Jingjing Zhao, Jinfeng Xu, Jieying Yang, Dijun Ouyang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Mengjuan Yang, Hao Chen, Chaopin Yang, Xinyi Yang, Jinqi You, Yuanyuan Chen, Minghao Ren, Yao Zhu, Jian-Chuan Xia, Tong Xiang
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma. Clinical and translational medicine 13 (5) (2023)
Qian Zhu, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Qiu-Zhong Pan, Zi-Qi Zhou, Meng-Jia Song, Jie-Ying Yang, Jun-Yi He, Yuan Liu, Min Li, Wan-Ming Hu, Chao-Pin Yang, Tong Xiang, Ming-Yuan Chen, Gang Ma, Ling Guo, Jian-Chuan Xia
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Journal of hematology & oncology 16 (1) (2023)
Yulong Han, Qiuzhong Pan, Zhixing Guo, Yufei Du, Yaojun Zhang, Yingying Liu, Jingjing Zhao, Jinfeng Xu, Jieying Yang, Dijun Ouyang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Mengjuan Yang, Hao Chen, Chaopin Yang, Xinyi Yang, Jinqi You, Yuanyuan Chen, Minghao Ren, Yao Zhu, Jian-Chuan Xia, Tong Xiang
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma. Clinical and translational medicine 13 (5) (2023)
Meng-Jia Song, Yue Huang, Ye Hong, Juan Liu, Jia Zhu, Suying Lu, Juan Wang, Feifei Sun, Junting Huang, Jiaqian Xu, Yan Tang, Jian-Chuan Xia, Yizhuo Zhang
PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma. Oncoimmunology 13 (1) (2023)
Yulong Han, Qiuzhong Pan, Zhixing Guo, Yufei Du, Yaojun Zhang, Yingying Liu, Jingjing Zhao, Jinfeng Xu, Jieying Yang, Dijun Ouyang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Mengjuan Yang, Hao Chen, Chaopin Yang, Xinyi Yang, Jinqi You, Yuanyuan Chen, Minghao Ren, Yao Zhu, Jian-Chuan Xia, Tong Xiang
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma. Clinical and translational medicine 13 (5) (2023)
Yulong Han, Qiuzhong Pan, Zhixing Guo, Yufei Du, Yaojun Zhang, Yingying Liu, Jingjing Zhao, Jinfeng Xu, Jieying Yang, Dijun Ouyang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Mengjuan Yang, Hao Chen, Chaopin Yang, Xinyi Yang, Jinqi You, Yuanyuan Chen, Minghao Ren, Yao Zhu, Jian-Chuan Xia, Tong Xiang
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma. Clinical and translational medicine 13 (5) (2023)
Yue Huang, Yingqin Zhu, Jieying Yang, Qiuzhong Pan, Jingjing Zhao, Mengjia Song, Chaopin Yang, Yulong Han, Yan Tang, Qijing Wang, Jia He, Yongqiang Li, Junyi He, Hao Chen, Desheng Weng, Tong Xiang, Jian-Chuan Xia
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma. Cell death & disease 13 (3) (2022)
Han Li, Fan Luo, Xingyu Jiang, Weijing Zhang, Tong Xiang, Qiuzhong Pan, Liming Cai, Jingjing Zhao, Desheng Weng, Yue Li, Yuhu Dai, Fengze Sun, Chaopin Yang, Yue Huang, Jieying Yang, Yan Tang, Yulong Han, Mian He, Yanna Zhang, Libing Song, Jian-Chuan Xia
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype. Journal for immunotherapy of cancer 10 (3) (2022)
Meng-Jia Song, Junyi He, Qiu-Zhong Pan, Jieying Yang, Jingjing Zhao, Yao-Jun Zhang, Yue Huang, Yan Tang, Qijing Wang, Jia He, Jiamei Gu, Yongqiang Li, Shiping Chen, Jianxiong Zeng, Zi-Qi Zhou, Chaopin Yang, Yulong Han, Hao Chen, Tong Xiang, De-Sheng Weng, Jian-Chuan Xia
Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression. Hepatology (Baltimore, Md.) 73 (5) (2022)
Fengze Sun, Yuanyuan Liu, Tingting Gong, Qiuzhong Pan, Tong Xiang, Jingjing Zhao, Yan Tang, Hao Chen, Yulong Han, Mengjia Song, Yue Huang, Han Li, Yuanyuan Chen, Chaopin Yang, Jieying Yang, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Ruiqing Peng, Jian-Chuan Xia
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin. Cell death & disease 12 (12) (2021)
Qian Zhu, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Qiu-Zhong Pan, Zi-Qi Zhou, Meng-Jia Song, Jie-Ying Yang, Jun-Yi He, Yuan Liu, Min Li, Wan-Ming Hu, Chao-Pin Yang, Tong Xiang, Ming-Yuan Chen, Gang Ma, Ling Guo, Jian-Chuan Xia
Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Journal of hematology & oncology 13 (1) (2020)
Qiu-Zhong Pan, Jia-Mei Gu, Jing-Jing Zhao, Yan Tang, Qi-Jing Wang, Qian Zhu, Meng-Jia Song, Yong-Qiang Li, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia
Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer. Clinical & translational immunology 9 (2) (2020)
Heping Liu, Yuxiang Ma, Chaopin Yang, Shangzhou Xia, Qiuzhong Pan, Hongyun Zhao, Wenfeng Fang, Xi Chen, Yang Zhang, Benyan Zou, Qiuyuan Li, Yang Wan, Hao Chen, Yan Tang, Jingjing Zhao, Desheng Weng, Liming Xia, Li Zhang, Jian-Chuan Xia
Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer. Clinical & translational immunology 9 (10) (2020)
Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 69 (5) (2020)
Mengjia Song, Qiuzhong Pan, Jieying Yang, Junyi He, Jianxiong Zeng, Shaoyan Cheng, Yue Huang, Zi-Qi Zhou, Qian Zhu, Chaopin Yang, Yulong Han, Yan Tang, Hao Chen, De-Sheng Weng, Jian-Chuan Xia
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma. British journal of cancer 123 (10) (2020)
Xiao-Fei Zhang, De-Sheng Weng, Ke Pan, Zi-Qi Zhou, Qiu-Zhong Pan, Jing-Jing Zhao, Yan Tang, Shan-Shan Jiang, Chang-Long Chen, Yong-Qiang Li, Hong-Xia Zhang, Alfred E Chang, Max S Wicha, Yi-Xin Zeng, Qiao Li, Jian-Chuan Xia
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells. Molecular carcinogenesis 56 (11) (2017)
Xu-Qiong Huang, Xiao-Fei Zhang, Jin-Hua Xia, Jie Chao, Qiu-Zhong Pan, Jing-Jing Zhao, Zi-Qi Zhou, Chang-Long Chen, Yan Tang, De-Sheng Weng, Jian-Hua Zhang, Jian-Chuan Xia
Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer. Chinese journal of cancer 36 (1) (2017)

Jian-Chuan Xia.css-eqlu8i{font-size:small;padding-left:4px;} (Jianchuan Xia, Jian Chuan Xia)

Publication Activity (10 Years)

Top Topics

Top Venues

Jian-Chuan Xia (Jianchuan Xia, Jian Chuan Xia)